SHU Lianghui, WANG Xingyue, CHAO Ya. Effect of cinacalcet on mineral metabolismand nutritional indexes of patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 115-117, 122. DOI: 10.7619/jcmp.20210462
Citation: SHU Lianghui, WANG Xingyue, CHAO Ya. Effect of cinacalcet on mineral metabolismand nutritional indexes of patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 115-117, 122. DOI: 10.7619/jcmp.20210462

Effect of cinacalcet on mineral metabolismand nutritional indexes of patients with maintenance hemodialysis

More Information
  • Received Date: January 24, 2021
  • Available Online: April 20, 2021
  • Published Date: April 14, 2021
  •   Objective  To observe the effect of cinacalcet on mineral metabolism and nutritional indexes of patients with maintenance hemodialysis (MHD).
      Methods  A total of 90 MHD patients in the Blood Purification Center of Wuxi City Ninth People's Hospital Affiliated to Soochow University were selected and randomly divided into observation group and control group, with 45 cases in each group. The control group was treated with basic therapy, and the observation group was treated with cinacalcet on the basis of basic therapy. The standard-reaching rates of mineral metabolism and nutritional indexes as well as Malnutrition-inflammation Score (MIS) were compared before and after treatment in both groups.
      Results  After treatment, the standard-reaching rates of blood calcium, blood phosphorus, intact parathyroid hormone (iPTH) and triglyceride in the observation group were significantly higher than those before treatment, and the standard-reaching rates of blood calcium, iPTH and triglyceride in the observation group were significantly higher than those in the control group (P < 0.05 or P < 0.01). After treatment, the MIS of the control group was (6.22±2.95) points, which was significantly higher than (4.22±1.82) points of the observation group (P < 0.01).
      Conclusion  Cinacalcet can effectively improve the level of mineral metabolism and nutritional status in MHD patients, improve prognosis and enhance the quality of life.
  • [1]
    封蕾, 杨杰, 李萍, 等. 电子智能辅助工具改善透析患者营养不良及矿物质骨代谢异常的观察研究[J]. 中国血液净化, 2020, 19(5): 301-304. doi: 10.3969/j.issn.1671-4091.2020.05.004
    [2]
    梁丹华, 谭荣韶, 刘岩, 等. 三种营养筛查工具对维持性血液透析病人透析相关性蛋白质-能量消耗的评价比较[J]. 肠外与肠内营养, 2017, 24(3): 138-142. https://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201703005.htm
    [3]
    于茜, 朱晗玉, 龙玲玲, 等. 骨化三醇口服或静脉给药联合西那卡塞治疗维持性血液透析患者继发性甲状旁腺功能亢进症的疗效观察[J]. 中华实用诊断与治疗杂志, 2020, 34(7): 678-682. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202007008.htm
    [4]
    王辉, 王云. 骨化三醇联合西那卡塞治疗血液透析患者继发性甲状旁腺功能亢进的疗效[J]. 中国血液净化, 2019, 18(1): 8-11. doi: 10.3969/j.issn.1671-4091.2019.01.002
    [5]
    袁芳, 陈星, 王畅, 等. 西那卡塞联合小剂量骨化三醇治疗重度继发性甲状旁腺功能亢进的效果及其对骨代谢的影响[J]. 中南大学学报: 医学版, 2017, 42(10): 1169-1173. doi: 10.11817/j.issn.1672-7347.2017.10.007
    [6]
    MIDDLETON J P, WOLF M. Second chances to improve ESRD outcomes with a second-generation calcimimetic[J]. JAMA, 2017, 317(2): 139-141. doi: 10.1001/jama.2016.18631
    [7]
    中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-950. doi: 10.3969/j.issn.1000-3614.2016.10.001
    [8]
    杨明正, 阚林, 陈正芳, 等. 西那卡塞对血液透析患者血清FGF23及心血管事件的影响[J]. 实用医学杂志, 2018, 34(24): 4158-4161. doi: 10.3969/j.issn.1006-5725.2018.24.035
    [9]
    宋亦琪, 倪丽, 陈靖. 维持性血液透析患者营养评估及相关进展[J]. 中国血液净化, 2018, 17(1): 51-53. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJH201801014.htm
    [10]
    瞿国美, 杨晶. 老年血液透析患者营养状态的评价分析[J]. 中国临床医生杂志, 2018, 46(1): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS201801016.htm
    [11]
    VILLARROEL P, MATTAR P, D'ESPESSAILLES A, et al. Calcium sensing receptor effects in adipocytes and liver cells: Implications for an adipose-hepatic crosstalk[J]. Arch Biochem Biophys, 2016, 607: 47-54. doi: 10.1016/j.abb.2016.08.017
    [12]
    舒亮辉, 朝亚. 综合营养评估法在维持性透析患者中的临床运用进展[J]. 中国血液净化, 2020, 19(2): 130-133. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJH202002019.htm
  • Related Articles

    [1]ZHU Rong, XIONG Zhaohui, CHEN Yunliang, LI Mengxin, WANG Haiquan. Effect of midazolam and dexmedetomidine in patients with septic shock during mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 124-127. DOI: 10.7619/jcmp.20223579
    [2]ZHU Guanneng, WANG Yang, SONG Haimiao, FENG Erwen. Analysis of risk factors and pathogenic bacteria of ventilator-associated pneumonia in patients with severe trauma undergoing mechanical ventilation in intensive care unit[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 101-104. DOI: 10.7619/jcmp.20214843
    [3]LU Jun, LIN Qian, ZHANG Dan, HU Hong. Effect of cluster nursing on ventilation time and nursing quality in mechanical ventilation neonates[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 53-55. DOI: 10.7619/jcmp.202007016
    [4]YANG Xuefeng. Effect of milrinone combined with high frequency ventilation on arterial blood gas index and mechanical ventilation time in neonates with persistent pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (11): 33-35,40. DOI: 10.7619/jcmp.201811009
    [5]TAO Yu. Cluster nursing intervention in prevention of ventilator-associated pneumonia in patients with mechanical ventilation in RICU[J]. Journal of Clinical Medicine in Practice, 2018, (6): 26-29. DOI: 10.7619/jcmp.201806008
    [6]WANG Miao. Effect of mechanical vibration sputum elimination in reducing pulmonary complications in ICU patients with mechanical ventilation after operation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 70-73. DOI: 10.7619/jcmp.201710022
    [7]PAN Jingya, WAN Wenxia, LI Xuemei. Nursing of RICU patients with mechanically ventilated in sequential ventilation critical period[J]. Journal of Clinical Medicine in Practice, 2016, (22): 27-29. DOI: 10.7619/jcmp.201622009
    [8]ZHANG Hong, SHEN Yuhui, CEHN Huaming. The curative effect analysis of nursing intervention on the continuous respiratory mechanical ventilation in treatment for neonatal respiratory failure[J]. Journal of Clinical Medicine in Practice, 2015, (18): 101-104. DOI: 10.7619/jcmp.201518032
    [9]CHEN Haiwei, LIANG Peng, SU Ning, WEN Jianhua, SU Meihua. The value and the influencing factors of modified sputum-sucking method in prevention and treatment of ventilator-associated pneumonia in patients with mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2015, (14): 27-29,42. DOI: 10.7619/jcmp.201514009
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019
  • Cited by

    Periodical cited type(31)

    1. 黄奇峰,郑鹏程,戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 .
    2. 孙燕,张新菊,李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 .
    3. 黄延峰,钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 .
    4. 程继华,孟俊娜,雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 .
    5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 .
    6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 .
    7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 .
    8. 张秀丽,余玉花,张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 .
    9. 林钧,陈玮,刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 .
    10. 岳斌,张巍,徐丽,郑华东,李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 .
    11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 .
    12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 .
    13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 .
    14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 .
    15. 孙嘉婧,于湘英,马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 .
    16. 卢凯丽,宋瑞捧,姜惠惠,高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 .
    17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 .
    18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 .
    19. 刘燕君,朱明敏,陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 .
    20. 刘婷,王莹,杨召娣,陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 .
    21. 王云枫,王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 .
    22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 .
    23. 陈聪,梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 .
    24. 张建,范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 .
    25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 .
    26. 阳玲,黄冠军,方涛,柴振华,朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 .
    27. 徐露,章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 .
    28. 房思思,屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 .
    29. 周芸,刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 .
    30. 李黎,张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 .
    31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 .

    Other cited types(0)

Catalog

    Article views (302) PDF downloads (13) Cited by(31)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return